715 related articles for article (PubMed ID: 19135915)
21. Community-acquired methicillin-resistant Staphylococcus aureus in surgically treated hand infections.
Imahara SD; Friedrich JB
J Hand Surg Am; 2010 Jan; 35(1):97-103. PubMed ID: 19962836
[TBL] [Abstract][Full Text] [Related]
22. [Antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus strains from outpatient individuals].
García-Agudo L; Huertas M; Asencio MÁ; Carranza R; García-Martos P
Rev Esp Quimioter; 2011 Jun; 24(2):91-5. PubMed ID: 21667001
[TBL] [Abstract][Full Text] [Related]
23. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA).
Mediavilla JR; Chen L; Mathema B; Kreiswirth BN
Curr Opin Microbiol; 2012 Oct; 15(5):588-95. PubMed ID: 23044073
[TBL] [Abstract][Full Text] [Related]
24. Methicillin-resistant Staphylococcus aureus: a community health threat.
Cataldo MA; Taglietti F; Petrosillo N
Postgrad Med; 2010 Nov; 122(6):16-23. PubMed ID: 21084777
[TBL] [Abstract][Full Text] [Related]
25. Community-acquired methicillin-resistant Staphylococcus aureus infections of the hand: prevalence and timeliness of treatment.
O'Malley M; Fowler J; Ilyas AM
J Hand Surg Am; 2009 Mar; 34(3):504-8. PubMed ID: 19258149
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary infections and community associated methicillin resistant Staphylococcus aureus: a dangerous mix?
Shilo N; Quach C
Paediatr Respir Rev; 2011 Sep; 12(3):182-9. PubMed ID: 21722847
[TBL] [Abstract][Full Text] [Related]
27. Why is community-associated MRSA spreading across the world and how will it change clinical practice?
Bassetti M; Nicco E; Mikulska M
Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S15-9. PubMed ID: 19560669
[TBL] [Abstract][Full Text] [Related]
28. An update on community-associated MRSA virulence.
Kobayashi SD; DeLeo FR
Curr Opin Pharmacol; 2009 Oct; 9(5):545-51. PubMed ID: 19726228
[TBL] [Abstract][Full Text] [Related]
29. Community-acquired methicillin-resistant Staphylococcus aureus infections.
Palavecino E
Clin Lab Med; 2004 Jun; 24(2):403-18. PubMed ID: 15177847
[TBL] [Abstract][Full Text] [Related]
30. Methicillin-resistant Staphyloccocus aureus in the community.
Amador-Miranda R; Bertrán-Pasarell J; González M; Conde A
Bol Asoc Med P R; 2008; 100(3):21-3. PubMed ID: 19227711
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
Huang V; Cheung CM; Kaatz GW; Rybak MJ
Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains.
Wang JT; Wang JL; Fang CT; Chie WC; Lai MS; Lauderdale TL; Weng CM; Chang SC
J Infect; 2010 Dec; 61(6):449-57. PubMed ID: 20875455
[TBL] [Abstract][Full Text] [Related]
33. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection.
Miller LG; Diep BA
Clin Infect Dis; 2008 Mar; 46(5):752-60. PubMed ID: 18220477
[TBL] [Abstract][Full Text] [Related]
34. Endocarditis: impact of methicillin-resistant Staphylococcus aureus in hemodialysis patients and community-acquired infection.
Kuo CB; Lin JC; Peng MY; Wang NC; Chang FY
J Microbiol Immunol Infect; 2007 Aug; 40(4):317-24. PubMed ID: 17712466
[TBL] [Abstract][Full Text] [Related]
35. Emergence of and risk factors for methicillin-resistant Staphylococcus aureus of community origin in intensive care nurseries.
Seybold U; Halvosa JS; White N; Voris V; Ray SM; Blumberg HM
Pediatrics; 2008 Nov; 122(5):1039-46. PubMed ID: 18977985
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.
Chua K; Laurent F; Coombs G; Grayson ML; Howden BP
Clin Infect Dis; 2011 Jan; 52(1):99-114. PubMed ID: 21148528
[TBL] [Abstract][Full Text] [Related]
37. Community-associated methicillin-resistant Staphylococcus aureus: risk factors for infection, and long-term follow-up.
Longtin Y; Sudre P; François P; Schrenzel J; Aramburu C; Pastore R; Gervaix A; Renzi G; Pittet D; Harbarth S
Clin Microbiol Infect; 2009 Jun; 15(6):552-9. PubMed ID: 19416294
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of methicillin-resistant Staphylococcus aureus.
Boucher HW; Corey GR
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S344-9. PubMed ID: 18462089
[TBL] [Abstract][Full Text] [Related]
39. Methicillin-resistant Staphylococcus aureus: risk factors associated with community-onset infections in Denmark.
Böcher S; Gervelmeyer A; Monnet DL; Mølbak K; Skov RL;
Clin Microbiol Infect; 2008 Oct; 14(10):942-8. PubMed ID: 18752595
[TBL] [Abstract][Full Text] [Related]
40. Current challenges in treating MRSA: what are the options?
Ratnaraja NV; Hawkey PM
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):601-18. PubMed ID: 18847401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
